Ostatné · NTRA
Natera, Inc.
Fundamenty firmy Healthcare · Diagnostics & Research · United States
Hodnotenie 0–10, vypočítané z údajov firmy
Analytici 22 hodnotení
silný nákup
- Najnižší cieľ
- 280,00
- Priemerný cieľ
- 361,16
- Najvyšší cieľ
- 475,00
- Potenciál
- −14,0 %
Odhad zisku na akciu (EPS)
| Obdobie | Odhad | Rozpätie | Pred rokom | Rast |
|---|---|---|---|---|
| tento štvrťrok | -0,24 | -0,61–0,13 | -0,64 | +61,7 % |
| budúci štvrťrok | -0,09 | -0,34–0,31 | 0,36 | −125,0 % |
| tento rok | -1,41 | -2,02–-0,63 | -1,52 | +7,1 % |
| budúci rok | -0,14 | -1,93–1,74 | -1,41 | +90,3 % |
Odhad tržieb
| Obdobie | Odhad | Pred rokom | Rast |
|---|---|---|---|
| tento štvrťrok | 707,1 mil. | 592,2 mil. | +19,4 % |
| budúci štvrťrok | 749,3 mil. | 665,5 mil. | +12,6 % |
| tento rok | 2,9 mld. | 2,3 mld. | +26,2 % |
| budúci rok | 3,5 mld. | 2,9 mld. | +20,6 % |
Nákupy a predaje manažérov insider
| Kto | Čo | Hodnota | Dátum |
|---|---|---|---|
| Rabinowitz MatthewOfficer and Director | predaj | 34,8 mil. | 15.09. |
| Rabinowitz MatthewOfficer and Director | predaj | 16,4 mil. | 11.09. |
| Moshkevich SolomonOfficer | predaj | 5,9 mil. | 02.09. |
| Chapman Steven LeonardChief Executive Officer | predaj | 545 041 | 01.09. |
| Fesko JohnPresident | predaj | 2,1 mil. | 10.08. |
| Sheena JonathanDirector | predaj | 2,0 mil. | 10.08. |
| Sheena JonathanDirector | predaj | 2,9 mil. | 07.08. |
| Rabinowitz MatthewOfficer and Director | predaj | 641 800 | 07.08. |
| Fesko JohnPresident | odmena v akciách | – | 06.08. |
| Brophy Michael BurkesChief Financial Officer | predaj | 216 030 | 04.08. |
| Rabinowitz Daniel AOfficer | predaj | 89 508 | 03.08. |
| Fesko JohnPresident | predaj | 79 057 | 03.08. |
Kto vlastní akcie
Slávni investori: Stanley Druckenmiller · 19.9 % Cathie Wood · 1.2 % Ray Dalio · 0.0 %
JPMORGAN CHASE & CO8,93 %
Blackrock Inc.7,57 %
Price (T.Rowe) Associates Inc6,26 %
Vanguard Capital Management LLC4,32 %
Vanguard Portfolio Management LLC4,01 %
FMR, LLC3,78 %
Wellington Management Group, LLP2,80 %
State Street Corporation2,54 %
O firme (popis z Yahoo Finance, anglicky)
Natera, Inc., a diagnostics company, engages in the development and commercialization of molecular testing services worldwide. It offers Signatera, a personalized ctDNA blood test for MRD assessment, early recurrence monitoring, and evaluation of treatment response in patients previously diagnosed with cancer; Latitude, a blood-based MRD test for colorectal cancer; Altera, a tissue based comprehensive genomic profiling test; and Empower, a hereditary cancer screening test. The company also provides Panorama, a non-invasive prenatal test; Horizon, a carrier screening test; Fetal Focus, a single-gene NIPT, or sgNIPT, that screens for 21 single-gene inherited conditions; and Vistara, a single-gene NIPT, which screens for 25 single-gene conditions. In addition, it offers Anora, which tests and analyzes miscarriage tissue from women who have experienced one or more pregnancy losses; Empower, a hereditary cancer screening test; Prospera, a test to assess active rejection in patients who have undergone solid organ transplantation; Renasight, a kidney gene panel test; and Constellation software, a cloud-based distribution model. Further, the company provides NateraCore, a platform to support the patient and provider experience; phlebotomy services; and EMR integration services. The company serves independent laboratories, national and regional reference laboratories, medical centers and physician practices for its screening tests, research laboratories, and pharmaceutical companies through its direct sales force and laboratory distribution partners, as well as Constellation licensees under its cloud-based distribution model. It has a partnership agreement with BGI Genomics Co., Ltd. to develop, manufacture, and commercialize NGS-based genetic testing assays for clinical and commercial use. The company has a collaboration with Diakonos Oncology Corp. to assess molecular response in patients with refractory melanoma. The company was formerly known as Gene Security Network, LLC and changed its name to Natera, Inc. in January 2012. Natera, Inc. was founded in 2003 and is headquartered in Austin, Texas.
Názor AI
Krátke zhodnotenie trendu, správ a blížiacich sa udalostí.
Technické signály
- Prekúpené – RSI 81 – rast je natiahnutý, hrozí korekcia
- Rastový trend – Kurz nad SMA50 aj SMA200, SMA50 nad SMA200
- Pri 52t maxime – Obchoduje sa pri ročnom maxime – silné momentum
Odporúčania
K tomuto aktívu zatiaľ nemáme odporúčanie.
Predikcie
Žiadne predikcie.
Súvisiace správy
Žiadne správy so značkou NTRA.